Lung Cancer

Michael O'Leary

New drug boosts disease-free survival in NSCLC

May represent a treatment shift to earlier use of targeted therapy against EGFR cancer CANCER DIGEST – Feb. 11, 2023 – Non-small cell...

Michael O'Leary

Drug for rare lung cancer receives FDA approval

CANCER DIGEST – Jan. 7, 2023 – The US FDA has approved a new treatment for a rare type of lung cancer following a clinical trial led by...

Michael O'Leary

New immunotherapy approach promises to improve cancer outcomes

CANCER DIGEST – Nov. 19, 2022 – Researchers at Albert Einstein College of Medicine have identified an additional protein cancer cells use...